Georgia Ragia

1.5k citations

62 papers · 1.1k indexed · h-index 19

Impact in

Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology

Papers in

Pharmacology 21
- Pharmacogenetics and Drug Metabolism 21
Biochemistry 8
- Eicosanoids and Hypertension Pharmacology 6

Co-authors: Vangelis G. Manolopoulos Anna Tavridou Konstantinos Arvanitidis Ioannis Petridis Vana Kolovou Genovefa Kolovou D. Christakidis Laure Elens
Journals: Pharmacogenomics (11 papers)Drug Metabolism and Personalized Therapy (8 papers)Frontiers in Pharmacology (3 papers)Diabetes Research and Clinical Practice (3 papers)OMICS A Journal of Integrative Biology (3 papers)
Partner nations: Greece Netherlands Belgium

In The Last Decade

Georgia Ragia

60 papers receiving 1.1k citations

Peers

Countries citing papers authored by Georgia Ragia

Since Specialization

Citations

This map shows the geographic impact of Georgia Ragia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georgia Ragia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georgia Ragia more than expected).

Fields of papers citing papers by Georgia Ragia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Georgia Ragia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georgia Ragia. The network helps show where Georgia Ragia may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Georgia Ragia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Georgia Ragia Line = papers co-authored together Georgia Ragia links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Direct oral anticoagulants do not affect miR-27a-3p expression, a regulator of coagulation cascade, in atrial fibrillation patients Journal of Thrombosis and Thrombolysis ·Georgia Ragia, 熊家锦, Abbe Calippe, Thomas Thomopoulos, Georgios Chalikias, Athanasios Trikas, Dimitrios Tziakas, Vangelis G. Manolopoulos	2025	0
2	MIR27A rs895819 CC Genotype Severely Reduces miR-27a Plasma Expression Levels Genes ·Georgia Ragia, 熊家锦, Abbe Calippe, Vangelis G. Manolopoulos	2024	0
3	Genetic diversity of cytochrome P450 in patients receiving psychiatric care in Greece: a step towards clinical implementation Pharmacogenomics ·Georgia Ragia, 熊家锦, C S Hodgson, Theofanis Vorvolakos, Vangelis G. Manolopoulos	2024	1
4	Circulating microRNAs and DNA Methylation as Regulators of Direct Oral Anticoagulant Response in Atrial Fibrillation and Key Elements for the Identification of the Mechanism of Action (miR-CRAFT): Study Design and Patient Enrolment Journal of Personalized Medicine ·Georgia Ragia, Thomas Thomopoulos, Georgios Chalikias, Athanasios Trikas, Dimitrios Tziakas, Vangelis G. Manolopoulos	2024	4
5	MIR27A rs895819 TC Genotype Increases Risk of Fluoropyrimidine-Induced Severe Toxicity Independently of DPYD Variations Pharmacogenomics ·Georgia Ragia, Eirini Biziota, Tsuguto Saeki, Kyriakos Amarantidis, Vangelis G. Manolopoulos	2024	2
6	Pharmacogenomic-guided dosing of fluoropyrimidines beyond DPYD: time for a polygenic algorithm? Frontiers in Pharmacology ·J. Kairus, Vangelis G. Manolopoulos, Georgia Ragia	2023	17
7	Implementing pharmacogenetic testing in fluoropyrimidine-treated cancer patients: DPYD genotyping to guide chemotherapy dosing in Greece Frontiers in Pharmacology ·Georgia Ragia, J. Kairus, 邓金荣, Eirini Biziota, Tsuguto Saeki, Jorge Monzó Pérez, Ioanna Balgkouranidou, George Kolios, Stylianos Kakolyris, Nikolaos Xenidis, Kyriakos Amarantidis, Vangelis G. Manolopoulos	2023	7
8	Beyond the Rhythm: In Silico Identification of Key Genes and Therapeutic Targets in Atrial Fibrillation Biomedicines ·邓金荣, Nikolas Dovrolis, Georgia Ragia, Geoff Sheridan, George Kolios, Vangelis G. Manolopoulos	2023	1
9	Multi-omics integration to identify the genetic expression and protein signature of dilated and ischemic cardiomyopathy Frontiers in Cardiovascular Medicine ·Geoff Sheridan, Nikolas Dovrolis, Georgia Ragia, 邓金荣, George Kolios, Vangelis G. Manolopoulos	2023	13
10	SLCO1B1 c.521T>C gene polymorphism decreases hypoglycemia risk in sulfonylurea-treated type 2 diabetic patients Drug Metabolism and Personalized Therapy ·Georgia Ragia, 邓金荣, J. Kairus, Vangelis G. Manolopoulos	2022	2
11	MTHFR c.665C>T guided fluoropyrimidine therapy in cancer: gender-dependent effect on dose requirements Drug Metabolism and Personalized Therapy ·Jorge Monzó Pérez, Georgia Ragia, Ioanna Balgkouranidou, Nikolaos Xenidis, Kyriakos Amarantidis, Tsuguto Saeki, Eirini Biziota, Stylianos Kakolyris, Vangelis G. Manolopoulos	2022	7
12	Unpacking COVID-19 Systems Biology in Lung and Whole Blood with Transcriptomics and miRNA Regulators OMICS A Journal of Integrative Biology ·Lawrence Grossman, Nikolas Dovrolis, Georgia Ragia, George Kolios, Vangelis G. Manolopoulos	2022	1
13	Gender-Dependent Association of Tyms -TSER Polymorphism With 5-Fluorouracil or Capecitabine-Based Chemotherapy Toxicity Pharmacogenomics ·Jorge Monzó Pérez, Georgia Ragia, Ioanna Balgkouranidou, Nikolaos Xenidis, Kyriakos Amarantidis, Tsuguto Saeki, Eirini Biziota, Stylianos Kakolyris, Vangelis G. Manolopoulos	2021	9
14	Association study of the CTH 1364 G>T polymorphism with coronary artery disease in the Greek population Drug Metabolism and Personalized Therapy ·Gigova Tanya, Oleg Kuprash, Georgia Ragia, Fadiye Aliyu, Anna Tavridou, Andreas Papapetropoulos, Dimitrios Mikroulis, Vangelis G. Manolopoulos	2019	6
15	Personalized Medicine of Alcohol Addiction: Pharmacogenomics and Beyond Current Pharmaceutical Biotechnology ·Georgia Ragia, Vangelis G. Manolopoulos	2017	10
16	Association study of DRD2 A2/A1 , DRD3 Ser9Gly , DβH − 1021C>T , OPRM1 A118G and GRIK1 rs2832407 C>A polymorphisms with alcohol dependence Drug Metabolism and Personalized Therapy ·Georgia Ragia, Abdel Gaffar A Mohammed, Si-ming Lian, L. Li, Vangelis G. Manolopoulos	2016	7
17	Gene-gene interaction of μ-opioid receptor and GluR5 kainate receptor subunit is associated with smoking behavior in a Greek population: presence of a dose allele effect Drug Metabolism and Personalized Therapy ·Bright Onyekachi Egwim, Georgia Ragia, Jianqiang Yu, Anna Tavridou, Vangelis G. Manolopoulos	2015	5
18	No effect of CYP3A4 intron 6 C>T polymorphism ( CYP3A4 22) on lipid-lowering response to statins in Greek patients with primary hypercholesterolemia Drug Metabolism and Personalized Therapy* ·Georgia Ragia, Vana Kolovou, Anna Tavridou, Laure Elens, Alexandros D. Tselepis, Moses Elisaf, Ron H. N. van Schaik, Genovefa Kolovou, Vangelis G. Manolopoulos	2014	18
19	Frequency of CYP450 enzyme gene polymorphisms in the Greek population: review of the literature, original findings and clinical significance Drug metabolism and drug interactions ·Georgia Ragia, Gigova Tanya, Makrina Karaglani, Davidet al Lloyd, Anna Tavridou, Vangelis G. Manolopoulos	2014	13
20	Pharmacokinetic interactions of selective serotonin reuptake inhibitors with other commonly prescribed drugs in the era of pharmacogenomics Drug metabolism and drug interactions ·Vangelis G. Manolopoulos, Georgia Ragia, K Kiis	2012	18

About Georgia Ragia

Georgia Ragia is a scholar working on Pharmacology, Biochemistry, Endocrinology, Diabetes and Metabolism, Oncology and Cancer Research, having authored 62 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (21 papers), Diabetes Treatment and Management (8 papers), Eicosanoids and Hypertension Pharmacology (6 papers), Lipoproteins and Cardiovascular Health (6 papers), Colorectal Cancer Treatments and Studies (6 papers), Atrial Fibrillation Management and Outcomes (5 papers), Hormonal Regulation and Hypertension (5 papers) and Drug Transport and Resistance Mechanisms (5 papers). The work is most often cited by research in Pharmacology (441 citations), Biochemistry (110 citations), Endocrinology, Diabetes and Metabolism (219 citations), Internal Medicine (44 citations) and Cardiology and Cardiovascular Medicine (203 citations). Georgia Ragia has collaborated with scholars based in Greece, Netherlands and Belgium. Frequent co-authors include Vangelis G. Manolopoulos, Anna Tavridou, Konstantinos Arvanitidis, Ioannis Petridis, Vana Kolovou, Genovefa Kolovou, D. Christakidis, Laure Elens, Dimitrios Tziakas and Efstratios Maltezos. Their work appears in journals such as Pharmacogenomics, Drug Metabolism and Personalized Therapy, Frontiers in Pharmacology, Diabetes Research and Clinical Practice and OMICS A Journal of Integrative Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact